Delivery Order SPE2DR25D3103-SPE2DR26F9R72
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,822.50 by the Defense Logistics Agency on December 16, 2025, for the supply of Vemlidy 25mg tablets (30-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 17, 2025. The contract will be performed at the awardee's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,541.90 by the Defense Logistics Agency (DLA) on December 9, 2025, with an ultimate completion date of December 10, 2025. This competitive award, which carries no set-aside designation, is for the supply of Vemlidy 25 mg tablets in quantities of 30 units. The contract employs firm fixed pricing and is classified as a delivery order, indicating it derives from a larger indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 24, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract valued at $23,466.99. The contract is a non-set-aside award funded by the Defense Logistics Agency's Medical Supply Chain, with a completion date of September 25, 2025. This delivery order represents a specific fulfillment under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on October 31, 2025, for Vemlidy 25 mg tablets in a package quantity of 30 units. This competitive, non-set-aside contract carries a ceiling value of $1,198.50 and is structured as a firm fixed-price delivery order, with an ultimate completion date of November 3, 2025. The place of performance is AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,202.38 by the Defense Logistics Agency (DLA) on December 10, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 11, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $25,330.47 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on December 17, 2025, with an ultimate completion date of December 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $7,299.76 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 16, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $7,245.84 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 2, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Vemlidy 25 mg tablets (quantity: 30 units) with a ceiling value of $8,367.01. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of December 10, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,265.45 on October 15, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30. This non-competitive delivery order is a firm fixed price contract with a completion date of October 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9R72Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,019.30 by the Defense Logistics Agency on December 22, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 tablets. The contract, executed as a firm fixed-price delivery order without set-aside provisions, is scheduled for completion by December 23, 2025, with performance taking place at the vendor's Conshohocken facility. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The delivery order aligns with AmerisourceBergen's established role as a critical federal medical supply vendor supporting military and veteran healthcare systems. The company's DLA contract vehicle enables the supply of a broad range of pharmaceutical products, specialty medications, and medical supplies to support defense health programs worldwide, including services to the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's selection reflects its demonstrated capability to meet federal procurement requirements through open competition, as evidenced by its extensive portfolio of competitively awarded contracts covering diverse pharmaceutical therapeutic domains and transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 12/21/25 |